John Lazarchick to Aged
This is a "connection" page, showing publications John Lazarchick has written about Aged.
Connection Strength
0.285
-
IgM Myeloma with Plasma Cell Leukemia: Case Report and Literature Review. Ann Clin Lab Sci. 2017 Sep; 47(5):611-619.
Score: 0.050
-
Characterization of Mast Cell Activation Syndrome. Am J Med Sci. 2017 03; 353(3):207-215.
Score: 0.048
-
Rituximab in the treatment of acquired factor VIII inhibitors. Thromb Haemost. 2006 Jul; 96(1):84-7.
Score: 0.023
-
Primary hepatic B-cell lymphoma of mucosa-associated lymphoid tissue. Arch Pathol Lab Med. 1999 Aug; 123(8):716-9.
Score: 0.014
-
Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study. Am J Clin Pathol. 2018 Oct 01; 150(5):393-405.
Score: 0.014
-
Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Institute/Food and Drug Administration guideline: results of a multicenter management study. Blood Coagul Fibrinolysis. 2018 Sep; 29(6):562-566.
Score: 0.013
-
HLA-Dr negative acute non-lymphocytic leukemia. Ann Clin Lab Sci. 1998 May-Jun; 28(3):150-2.
Score: 0.013
-
Assessment of Bleeding and Thrombosis Based on Aspirin Responsiveness after Continuous-Flow Left Ventricular Assist Device Placement. ASAIO J. 2017 Sep/Oct; 63(5):578-587.
Score: 0.013
-
D-Dimer Use and Pulmonary Embolism Diagnosis in Emergency Units: Why Is There Such a Difference in Pulmonary Embolism Prevalence between the United States of America and Countries Outside USA? PLoS One. 2017; 12(1):e0169268.
Score: 0.012
-
The effects of desmopressin and 6% hydroxyethyl starch on factor VIII:C. Anesth Analg. 1996 Oct; 83(4):804-7.
Score: 0.012
-
Evaluation of the role of secretory sphingomyelinase and bioactive sphingolipids as biomarkers in hemophagocytic lymphohistiocytosis. Am J Hematol. 2013 Nov; 88(11):E265-72.
Score: 0.010
-
Cutaneous presentation of T-cell prolymphocytic leukemia. Cutis. 2013 Feb; 91(2):87-91.
Score: 0.009
-
Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomes. J Thorac Cardiovasc Surg. 2011 Jun; 141(6):1469-77.e2.
Score: 0.008
-
Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature. Hematol Oncol. 2011 Jun; 29(2):100-6.
Score: 0.008
-
The laboratory diagnosis of lupus anticoagulants. Arch Pathol Lab Med. 1989 Feb; 113(2):177-80.
Score: 0.007
-
Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery. Ann Thorac Surg. 2008 May; 85(5):1669-76; discussion 1676-7.
Score: 0.007
-
Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations. Thromb Haemost. 2008 Mar; 99(3):616-22.
Score: 0.007
-
Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus. Liver Transpl. 2007 Jun; 13(6):904-12.
Score: 0.006
-
Factor V inhibitor associated with immune complex formation. Arch Pathol Lab Med. 1986 May; 110(5):448-51.
Score: 0.006
-
Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations. Blood. 1998 Jun 01; 91(11):4188-96.
Score: 0.003
-
Pyogenic liver abscess. Mayo Clin Proc. 1973 May; 48(5):349-55.
Score: 0.002